Nevus sebaceous
(Redirected from Nevus sebaceous of Jadassohn)
== Nevus Sebaceous ==
Nevus sebaceous, also known as nevus sebaceus of Jadassohn, is a congenital, benign hamartoma of the skin that typically presents at birth or in early childhood. It is characterized by an overgrowth of the sebaceous glands, hair follicles, and other epidermal structures.
Presentation[edit | edit source]
Nevus sebaceous usually appears as a solitary, well-demarcated, yellow-orange plaque. It is most commonly found on the scalp, but it can also occur on the face, neck, or other areas of the body. The lesion tends to be hairless and may become more pronounced and nodular during puberty due to hormonal changes.
Pathophysiology[edit | edit source]
The exact cause of nevus sebaceous is not fully understood, but it is believed to result from a post-zygotic mutation in the HRAS or KRAS genes. These mutations lead to the abnormal development of the epidermis, sebaceous glands, and other skin appendages.
Diagnosis[edit | edit source]
Diagnosis of nevus sebaceous is primarily clinical, based on the characteristic appearance of the lesion. A skin biopsy may be performed to confirm the diagnosis and to rule out other conditions. Histologically, nevus sebaceous shows hyperplasia of the sebaceous glands and other epidermal structures.
Complications[edit | edit source]
While nevus sebaceous is generally benign, there is a risk of secondary neoplasms developing within the lesion. These can include basal cell carcinoma, squamous cell carcinoma, and other benign or malignant tumors. Regular monitoring and, in some cases, prophylactic excision are recommended to manage this risk.
Treatment[edit | edit source]
Treatment options for nevus sebaceous include surgical excision, which is often recommended to prevent the development of secondary neoplasms. Other treatments, such as laser therapy, may be used to improve the cosmetic appearance of the lesion.
Prognosis[edit | edit source]
The prognosis for individuals with nevus sebaceous is generally good, especially if the lesion is monitored regularly and treated appropriately. The risk of malignant transformation is relatively low but warrants careful observation.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD